Attached files
| file | filename |
|---|---|
| EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - Ocata Therapeutics, Inc. | ocata_ex2101.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Ocata Therapeutics, Inc. | Financial_Report.xls |
| EX-31.1 - CERTIFICATION - Ocata Therapeutics, Inc. | ocata_ex3101.htm |
| EX-31.2 - CERTIFICATION - Ocata Therapeutics, Inc. | ocata_ex3102.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Ocata Therapeutics, Inc. | ocata_ex2302.htm |
| EX-32.1 - CERTIFICATION - Ocata Therapeutics, Inc. | ocata_ex3201.htm |
| 10-K - ANNUAL REPORT - Ocata Therapeutics, Inc. | ocata_10k-123114.htm |
| EX-32.2 - CERTIFICATION - Ocata Therapeutics, Inc. | ocata_ex3202.htm |
| EX-10.30 - 2014 STOCK OPTION AND INCENTIVE PLAN AND FORMS OF OPTION AGREEMENTS THEREUNDER - Ocata Therapeutics, Inc. | ocata_ex1030.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements (No. 333-109145, 333-127726, 333-162434, 333-165757 and
333-175019) on Form S-8 and (No. 333-192696, 333-199311, 333-199309, 333-197255) on Form S-3 of Ocata Therapeutics, Inc. and subsidiary,
formerly Advanced Cell Technology, Inc. (collectively, the “Company”) of our report dated April 1, 2014, except for
the reclassification paragraph in Note 2 as to which the date is March 16, 2015, relating to our audits of the consolidated financial
statements, which includes an emphasis paragraph relating to an uncertainty as to the Company’s ability to continue as a
going concern, which appear in this Annual Report on Form 10-K of the Company for
the year ended December 31, 2014.
/s/SingerLewak LLP
Los Angeles, California
March 16, 2015